Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular system (alternatively, Blood vessel for molecular specificity) (None for "blood pool" or "vasculature" as a molecule; often VS is used for "vascular system" but not standard)
- Target
- None for "blood pool" or "vasculature" as a molecule; often VS is used for "vascular system" but not standard
- Molecular classification
- Other (Anatomical structure, not a molecular class or protein family)
01
Overview
The vasculature or blood pool refers to the body’s system of arteries, veins, and capillaries that distribute blood to all tissues, supplying oxygen/nutrients and removing waste. “Blood pool” is sometimes used in imaging to describe the compartment containing circulating blood, especially as targeted by intravascular contrast agents for visualizing vessel anatomy or function. Neither term denotes a discrete molecular target for therapeutic drugs nor a receptor/enzyme. This entry is not a correct designation for a canonical drug target and should be replaced or subdivided into molecular components (e.g., “Vascular endothelial growth factor receptor”, “Endothelial nitric oxide synthase”) if precise targeting is intended.
- Other names
- Vascular systemBlood vesselsCirculatory systemCardiovascular system
02
Mechanism of action
Intravascular contrast agents stay within blood pool/vasculature, enhancing vessel visibility for diagnostic imaging (noncovalent binding to albumin or size-exclusion via polymeric chelates)
03
Biological functions
Transport of oxygen and nutrientsRemoval of waste productsRegulation of blood pressureImmune cell trafficking (via endothelial cells)
04
Disease associations
Cardiovascular disease (e.g., atherosclerosis, aneurysm, varicose veins)Cancer (via tumor vasculature, angiogenesis)Inflammation (vasculitis, structural vessel anomalies)
05
Safety considerations
Contrast agent toxicity (e.g., gadolinium retention, allergic reactions)Vascular injury, thrombosis, hemorrhage
06
Interacting drugs
Contrast agents for imaging (e.g., gadofosveset trisodium, gadomelitol)
07
Biomarkers
Vessel permeabilityBlood flowStatic blood pooling (imaging endpoints)
Beyond the preview
Go deeper on Vascular system (alternatively, Blood vessel for molecular specificity) (None for "blood pool" or "vasculature" as a molecule; often VS is used for "vascular system" but not standard).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vascular system (alternatively, Blood vessel for molecular specificity) (None for "blood pool" or "vasculature" as a molecule; often VS is used for "vascular system" but not standard).